Kinnate Biopharma Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2021 to Q1 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Kinnate Biopharma Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2021 to Q1 2024.
  • Kinnate Biopharma Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 20, 2024 was 47.2M shares, a 1.41% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 47.2M +656K +1.41% Mar 20, 2024 10-K 2024-03-28
Q3 2023 47.1M +2.95M +6.68% Nov 3, 2023 10-Q 2023-11-09
Q2 2023 47.1M +2.95M +6.68% Aug 4, 2023 10-Q 2023-08-08
Q1 2023 46.6M +2.62M +5.96% Mar 10, 2023 10-K 2023-03-15
Q3 2022 44.2M +469K +1.07% Nov 7, 2022 10-Q 2022-11-10
Q2 2022 44.1M +470K +1.08% Aug 5, 2022 10-Q 2022-08-11
Q1 2022 43.9M +445K +1.02% Mar 25, 2022 10-K/A 2022-05-12
Q3 2021 43.7M Nov 9, 2021 10-Q 2021-11-10
Q2 2021 43.7M Aug 10, 2021 10-Q 2021-08-16
Q1 2021 43.5M May 10, 2021 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.